Unquote Private Equity Podcast: Back for secondaries
This week, the Unquote Podcast tackles secondaries - featuring a panel discussion with Mill Reef Capital's Nico Taverna, OTPP's Joe Topley and Ely Place Partners' Daniel Roddick.
As investors pause for breath, the secondaries market has ground to a halt. But when activity begins again, will LPs be willing to take a pricing hit? And where will buyer and seller expectations meet? Katharine Hidalgo sets the scene with Unquote associate editor Denise Ko Genovese before a panel discussion featuring three secondaries specialists.
0:00 – Intro
1:15 – Grinding to a halt
2:03 – Panel discussion with Nico Taverna, Joe Topley and Daniel Roddick
16:40 – Waiting game
Theme music: ©2012 Kick Up The Fire
You can listen to the podcast in the audio player above, as well as your favourite podcasting platforms, including Spotify and Apple Podcasts.
More on Secondaries
Covid-19, oversubscribed funds fuel interest in early secondaries
Early secondaries are tipped to become more plentiful in the coming months, but market observers urge caution to mitigate potential pitfalls
Secondaries update: Unigestion’s David Swanson
Secondaries activity is recovering from the initial coronavirus-related shock, with good prospects for GP-led secondaries deals
Secondary market update: coming out of hibernation
After a pause in activity, the market is gearing up for a busy final quarter, says Rede Partners' Adam Turtle
EQ Asset Management eager to deploy following double fund close
EQ says it has completed five acquisitions through its secondaries fund since the outbreak of Covid-19
Latest News
Deutsche Beteiligungs AG announces supervisory board changes
Tom Alzin and Jannick Hunnecke will join, while Rolf Scheffels is to leave when his term ends
TriSpan Opportunities Fund II holds first close
Fund focuses on investment opportunities in the lower-mid-market across North America and Europe
Duff & Phelps appoints Bretag
Frank Bretag joins from Georgieff Capital Advisors and focuses on the industrial goods sector
Kartesia in €32m refinancing for Enterprise-backed Nu-Med
Enterprise Investors acquired a minority stake in the oncology company in 2013